<DOC>
	<DOC>NCT00693199</DOC>
	<brief_summary>The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.</brief_summary>
	<brief_title>Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Terazosin</mesh_term>
	<criteria>1. Men 50 years or older 2. with LUTS [defined as International Prostate Symptom Score (IPSS) &gt;= 10]. 3. Stage 1 or 2 essential hypertension (SBP &gt;= 140 mm Hg and &lt; 180 mm Hg and/or DBP &gt;= 90 mm Hg and &lt; 110 mm Hg) 1. A history of postural hypotension 2. Secondary hypertension 3. Prostate cancer 4. Prostate surgery or other intervention 5. Use of any agents to influence the LUTS symptoms in the last 4 weeks 6. Other severe diseases</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Amlodipine</keyword>
	<keyword>Terazosin</keyword>
	<keyword>Lower Urinary Tract Symptoms (LUTS)</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>International Prostate Symptom Score (IPSS)</keyword>
	<keyword>Quality Of Life (QOL)</keyword>
</DOC>